Latest News about Illumina
Recent news which mentions Illumina
Delivering the Future of Diagnostics and Precision Oncology
September 09, 2022
Tickers
ILMN
Latest Research at ESMO Congress 2022 Showcases the Impact of Comprehensive Genomic Profiling for Cancer Patients
September 07, 2022
Tickers
ILMN
Tickers
ILMN
A New Kind of Liquid Biopsy
August 29, 2022
Tickers
ILMN
Illumina Genomics Forum To Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics
August 24, 2022
Tickers
ILMN
Minderoo Foundation and Illumina Commit $40M AUD To Apply Advanced Genomics to Marine Conservation
August 17, 2022
Tickers
ILMN
Tickers
ILMN
Tickers
ILMN
Tickers
ILMN
Best Stocks To Buy Now: July 23, 2022
July 23, 2022
From Best Stocks
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
July 14, 2022
Tickers
ILMN
Best Stocks To Buy Now: Monday, May 30, 2022
May 30, 2022
From Best Stocks
Tickers
ILMN
Illumina Partners With Allelica, Inc.
May 11, 2022
Tickers
ILMN
Tickers
ILMN
How Collaboration Is Driving the Next Wave of Genomics
April 29, 2022
Tickers
ILMN
Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
April 27, 2022
Tickers
ILMN
Tickers
ILMN
Tickers
ILMN
Illumina's Chief Financial Officer, Sam Samad, Selected As a San Diego Business Journal 2022 CFO of the Year
April 18, 2022
Tickers
ILMN
Illumina Expands Access to Genomics in Latin America Through New State-of-the-Art Solution Center
April 13, 2022
Tickers
ILMN
John Frank Joins Illumina as Chief Public Affairs Officer
April 12, 2022
Tickers
ILMN
How Genomics Will Support Gorilla Conservation
April 06, 2022
Tickers
ILMN
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.